PROF
Profound Medical Corp
NASDAQ: PROF · HEALTHCARE · MEDICAL DEVICES
$7.22
-0.69% today
Updated 2026-05-06
Market cap
$262.04M
P/E ratio
—
P/S ratio
16.28x
EPS (TTM)
$-1.41
Dividend yield
—
52W range
$4 – $9
Volume
0.2M
Profound Medical Corp (PROF) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.88M | $-4.94M | $-10.79M | $-11.81M | $-13.43M | $-15.45M | $-20.57M | $-22.36M | $-25.80M | $-22.61M | $-23.45M | $-53.34M |
| Capital expenditures | $61283.00 | $120350.00 | $808842.00 | $369502.00 | $32000.00 | $2.00 | $350000.00 | $593000.00 | $0.00 | $1.00 | $0.00 | $245726.00 |
| Depreciation | $84896.00 | $85772.00 | $139132.00 | $693310.00 | $1.23M | $1.55M | $1.54M | $1.88M | $1.60M | $929000.00 | $936000.00 | — |
| Stock-based comp | $190333.00 | $464608.00 | $745151.00 | $1.06M | $797485.00 | $1.28M | $3.02M | $7.21M | $4.24M | $3.42M | $2.58M | $5.49M |
| Free cash flow | $-2.94M | $-5.06M | $-11.60M | $-12.18M | $-13.46M | $-15.45M | $-20.92M | $-22.95M | $-25.80M | $-22.61M | $-23.45M | $-53.59M |
| Investing cash flow | $-61283.00 | $-6.49M | $6.63M | $-793183.00 | $-189000.00 | $-192789.00 | $-350000.00 | $-593000.00 | — | — | — | — |
| Financing cash flow | $2.74M | $18.73M | $11.83M | $6.12M | $27.81M | $6.80M | $87.43M | $5.95M | $7.03M | $1.76M | $54.70M | — |
| Dividends paid | — | $0.00 | $0.00 | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | $0.00 | — | — | — | — | — | — | — | — | — | — |